CFGS
ALXN

Concourse Financial Group Securities’s Alexion Pharmaceuticals ALXN Stock Holding History

Concourse Financial Group Securities’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-105
Closed -$19K – 2521
2021
Q2 		$19K Sell
105
-29
-22% -$4.98K ﹤0.01% 1673
2021
Q1 		$20K Sell
134
-189
-59% -$29.2K ﹤0.01% 1575
2020
Q4 		$50K Buy
323
+13
+4% +$1.67K ﹤0.01% 1156
2020
Q3 		$35K Buy
310
+108
+53% +$11.7K ﹤0.01% 1187
2020
Q2 		$23K Sell
202
-1,707
-89% -$181K ﹤0.01% 1258
2020
Q1 		$171K Buy
+1,909
New +$187K 0.02% 505
2019
Q2 		– Sell
-544
Closed -$70.1K – 2451
2019
Q1 		$73K Buy
544
+336
+162% +$41.8K 0.01% 758
2018
Q4 		$20K Buy
208
+13
+7% +$1.54K ﹤0.01% 1162
2018
Q3 		$27K Buy
+195
New +$24.5K 0.01% 773

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Concourse Financial Group Securities's ALXN Position: Q3 2021 in Review

Concourse Financial Group Securities sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 105 shares — an estimated $19K sold.

Concourse Financial Group Securities first reported a position in ALXN in Q3 2018 and held it in 9 quarters. The position peaked at $171K in Q1 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Concourse Financial Group Securities reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Concourse Financial Group Securities sold 105 Alexion Pharmaceuticals shares in Q3 2021, an estimated $19K.
  • Concourse Financial Group Securities first reported a position in Alexion Pharmaceuticals in Q3 2018 and held it in 9 quarters.
  • Concourse Financial Group Securities's Alexion Pharmaceuticals position peaked at $171K in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Concourse Financial Group Securities's 13F filing for Q3 2021, filed 9 Nov 2021.